Skip to main content
SpringerLink
Log in

Erectile dysfunction and Peyronie’s disease in patient with retroperitoenal fibrosis

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

The aim of this study is to determine the sexual dysfunction in patient with retroperitoneal fibrosis (RPF) and also we explored probability of Peyronie’s disease (PD) in this patient group and to compare this with the controls.

Materials and methods

Ten of 17 male RPF patients formed the basis of this study. Patient’s age, concomitant diseases were recorded. The diagnosis of PD was based on a palpable penile plaque or acquired penile curvature. Age-matched 88 patients who were admitted to our outpatient clinic with elevated PSA level served as the control group. All patients were asked to complete the IIEF-5 questionnaire. The severity of the erectile dysfunction (ED) was classified into four categories: severe (5–7), moderate (8–16), mild (17–21), and no ED (22–25). Concomitant systemic diseases were recorded. Statistical analyses were done by the Fisher’s exact test and an unpaired-sample t-test.

Results

Patients with severe ED or no sexual intercourse in the study group and the control group during the study period were found to be 7 and 14, respectively. The median IIEF-5 score in RPF patients and the control group was 9.8 (min: 5 to max: 23) and 19 (min: 5 to max: 25), respectively. The differences between groups were statistically significant (P = 0.002). In particular, ED was reported in eight RPF patients (80%) which was severe in six (60%) and moderate in two (20%). ED was reported in 45 patients in the control group (51%) which was severe in 14 (15.9%), mild in 25 (28.4%), and moderate in six (6.8%). Patients with RPF had a significant tendency for severe ED compared with the control group (P = 0.0042). Two patients in the RPF group (20%) and one patient in the control group (1.1%) were found to have a penile plaque (P = 0.0279). Relative risk for developing a penile plague was found to be 0.8 in RPF.

Conclusion

RPF patients are found to be more prone to developing ED. Penile plaque formation was identified in RPF patients, which may be presumed to relate to the pathological changes of the RPF process, but it remains unclear that these patients demonstrate a higher incidence of plaque formation than the normal population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

RPF:

Retroperitoneal fibrosis

PD:

Peyronie’s disease

ED:

Erectile dysfunction

IIEF-5:

International index of erectile function-5

TGF-β1:

Transforming growth factor b1

PSA:

Prostate specific antigen

References

  1. Debruyne FM, Bogman MJ, Ypma AF (1982) Retroperitoneal fibrosis in the scrotum. Eur Urol 8(1):45–48

    PubMed  CAS  Google Scholar 

  2. Buff DD, Bogin MB, Faltz LL (1989) Retroperitoneal fibrosis: report of selected cases and a review of the literature. N Y State J Med 89(9):511–516

    PubMed  CAS  Google Scholar 

  3. van Bommel EFH, van Spengler J, van der Hoven B et al (1991) Retroperitoneal fibrosis: report of 12 cases and review of the literature. Neth J Med 39:338–345

    PubMed  Google Scholar 

  4. Birnberg FA, Vinstein AL, Gorlick G et al (1982) Retroperitoneal fibrosis in children. Radiology 145:59–61

    PubMed  CAS  Google Scholar 

  5. Koep L, Zuidema GD (1977) The clinical significance of retroperitoneal fibrosis. Surgery 81:250–257

    PubMed  CAS  Google Scholar 

  6. Gilkeson GS, Allen NB (1996) Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 22:23–38

    Article  PubMed  CAS  Google Scholar 

  7. Haag SM, Hauck EW, Szardening-Kirchner C et al (2007) Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie’s disease. Eur Urol 51(1):255–261

    Article  PubMed  CAS  Google Scholar 

  8. Wespes E, Amar E, Hatzichristou DG et al (2002) EAU guidelines on erectile dysfunction (Update March 2004). Eur Urol 41:1–5

    Article  PubMed  Google Scholar 

  9. Rosen RC, Cappelleri JC, Smith MD et al (1999) Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile function. Int J Impot Res 11:319–326

    Article  PubMed  CAS  Google Scholar 

  10. Bellastella A, Esposito D, Conte M et al (2005) Sexuality in aging male. J Endocrinol Invest 28(11):55–60

    PubMed  CAS  Google Scholar 

  11. Drieskens O, Blockmans D, van den Bruel A et al (2002) Riedel’s thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomography findings. Clin Nucl Med 27:413–415

    Article  PubMed  Google Scholar 

  12. Dehner LP, Coffin CM (1998) Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol 15:161–173

    PubMed  CAS  Google Scholar 

  13. Hellstrom HR, Perez-Stable EC (1966) Retroperitoneal fibrosis with disseminated vasculitis and intrahepatic sclerosing cholangitis. Am J Med 40:184–187

    Article  PubMed  CAS  Google Scholar 

  14. Smith BH (1966) Peyronie’s disease. Amer J Clin Path 45:670–678

    PubMed  CAS  Google Scholar 

  15. Schwarzer U, Sommer F, Klotz T et al (2001) The prevalence of Peyronie’s disease: results of a large survey. BJU Int 88:727–730

    Article  PubMed  CAS  Google Scholar 

  16. Kadioglu A, Oktar T, Kandirali E et al (2004) Incidentally diagnosed Peyronie’s disease in men presenting with erectile dysfunction. Int J Impot Res 16:540–543

    Article  PubMed  CAS  Google Scholar 

  17. Kadioglu A, Tefekli A, Erol B et al (2002) A retrospective review of 307 men with Peyronie’s disease. J Urol 168(3):1075–1079

    Article  PubMed  Google Scholar 

  18. El-Sakka AI, Hassoba HW, Pillarisetty RJ (1997) Peyronie’s disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 158:1391–1394

    Article  PubMed  CAS  Google Scholar 

  19. Anderson MS, Shankey TV, Lubrano T et al (2000) Inhibition of Peyronie’s plaque fibroblast proliferation by biologic agents. Int J Impot Res 12(Suppl 3):25–31

    Article  Google Scholar 

  20. Somers KD, Dawson DM, Wright GL et al (1982) Cell culture of Peyronie’s disease plaque and normal penile tissue. J Urol 127(3):585–588

    PubMed  CAS  Google Scholar 

  21. Kanazawa S, Miyake T, Kakinuma T et al (2005) The expression of platelet-derived growth factor and connective tissue growth factor in different types of abdominal aortic aneurysms. J Cardiovasc Surg (Torino) 46(3):271–278

    CAS  Google Scholar 

  22. Ramshaw AL, Roskell DE, Parums DV (1994) Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol 47(8):721–727

    Article  PubMed  CAS  Google Scholar 

  23. Moriya H, Ishida A, Nakabayashi I et al (1999) Juxtaglomerular cell tumor with retroperitoneal fibrosis and secondary immune-complex glomerulonephritis: a possible contribution of the renin angiotensin system to renal fibrosis. Am J Kidney Dis 34(3):10

    Article  Google Scholar 

  24. Mulhall JP, Branch J, Lubrano T et al (2003) Radiation increases fibrogenic cytokine expression by Peyronie’s disease fibroblasts. J Urol 170(1):281–284

    Article  PubMed  CAS  Google Scholar 

  25. Whelan JS, Reznek R, Daniell SJN et al (1991) Computed tomography (CT) and ultrasound (US) guided core biopsy in the management of non-Hodgkin’s lymphoma. Br J Cancer 63(3):460–462

    PubMed  CAS  Google Scholar 

  26. Mitchinson MJ (1970) The pathology of idiopathic retroperitoneal fibrosis. J Clin Path 23:681–689

    Article  PubMed  CAS  Google Scholar 

  27. Akkus E, Carrier S, Baba K et al (1997) Structural alterations in the tunica albuginea of the penis: impact of Peyronie’s disease, ageing and impotence. Br J Urol 79:47–53

    PubMed  CAS  Google Scholar 

  28. El-Sakka AI (2006) Prevalence of Peyronie’s disease among patients with erectile dysfunction. Eur Urol 49(3):564–569

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Marmara University School of Medicine, Tophanelioğlu Cad. No: 13-15, Altunizade, Istanbul, 34662, Turkey

    Cem Akbal, Yılören Tanıdır, Mahir Bülent Özgen & Ferruh Şimşek

Authors
  1. Cem Akbal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yılören Tanıdır
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahir Bülent Özgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ferruh Şimşek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cem Akbal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akbal, C., Tanıdır, Y., Özgen, M.B. et al. Erectile dysfunction and Peyronie’s disease in patient with retroperitoenal fibrosis. Int Urol Nephrol 40, 971–975 (2008). https://doi.org/10.1007/s11255-008-9381-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-008-9381-4

Keywords

Search

Navigation